The Delhi High Court has restrained a pharmaceutical firm from infringing the copyright of Mankind Pharma in the contents of its website.
Justice Prathiba M Singh said considering the evidence and the content of the website of Lee Pharmaceuticals of Lee House being identical, a permanent injunction is liable to be granted in favour of plaintiff Mankind Pharma Ltd and against the defendant.
"...a permanent injunction is liable to be granted in favour of the plaintiff against the defendant restraining the defendant from in any manner infringing the copyright of the plaintiff in the contents of its website www.mankindpharma.com. Further, the defendant is also restrained from passing off its business as being affiliated to that of the plaintiff. The suit is accordingly, decreed..," the court said.
Mankind Pharma said it was selling various medicinal preparations and over the counter drugs (OTCs) and has various domain names registered in its name with the mark 'MANKIND', however, its main website is www.mankindpharma.com.
It said that Lee Pharmaceuticals was incorporated in 2013 and the plaintiff came to know in February 2014, that the defendant has a website www.leepharmaceuticals.in.
A perusal of the website revealed that the entire website, including the photographs, images, etc. of the plaintiff has been copied by the defendant, it said.
As no one appeared for the defendant firm even after being served with the notice, the court proceeded ex-parte.
After going through the screenshots of the websites of both the companies, the court said use of such identical content is not only infringement of the plaintiff's copyright but could also lead to misrepresentation that the defendant is either affiliated to, or is a group company of the plaintiff.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
